Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with 125I seeds-Reference-Cited by-同舟云学术

Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with 125I seeds

Published:2010-01 Issue:1 Volume:9 Page:8-14
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Garrán Cristina,Ciérvide Raquel,Cambeiro Mauricio,Moreno-Jiménez Marta,Ramos Luis I.,Martínez-Monge Rafael

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. A dose-response study for I-125 prostate implants;Stock;Int J Radiat Oncol Biol Phys,1998

2. Permanent I-125 prostate brachytherapy performed in the community setting: Validation of the benefit of post-implant ct dosimetry and the prostate D90 as a predictor of 5-year bNED outcome;Linstadt;Brachytherapy,2007

3. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V(100) superior to D(90)?;Papagikos;Brachytherapy,2005

4. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy;Potters;Int J Radiat Oncol Biol Phys,2001

5. Dosimetry and cancer control after low-dose-rate prostate brachytherapy;Robert;Int J Radiat Oncol Biol Phys,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer;Brachytherapy;2017-09

2. Dose–Response Relationship in Permanent Implant Brachytherapy for Prostate Cancer;Interstitial Prostate Brachytherapy;2013